APO Research
Talk to an analyst

APO RESEARCH · REPORT

Penicillin Intermediate

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Penicillin Intermediate Market Analysis and Forecast 2026-2032

29 December 2025210 pages

Choose your research edition.

Industry ResearchPenicillin Intermediate Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Penicillin Intermediate Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Penicillin Intermediate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Penicillin Intermediate Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Penicillin Intermediate Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Penicillin Intermediate market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Penicillin Intermediate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Penicillin Intermediate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Penicillin Intermediate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Penicillin Intermediate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Penicillin Intermediate include Sinopharm Weiqida Pharmaceutical, Kasugamycin hydrochloride, Shanghai Hongsheng, Apeloa Pharmaceutical, The United Laboratories International Holdings Limited, Sichuan Kelun Pharmaceutical, Jiangxi Huabang, North China Pharmaceutical Company and Henan Huaxing, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Penicillin Intermediate, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Penicillin Intermediate, also provides the sales of main regions and countries. Of the upcoming market potential for Penicillin Intermediate, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Penicillin Intermediate sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Penicillin Intermediate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Penicillin Intermediate sales, projected growth trends, production technology, application and end-user industry.

Penicillin Intermediate Segment by Company

Sinopharm Weiqida Pharmaceutical

Kasugamycin hydrochloride

Shanghai Hongsheng

Apeloa Pharmaceutical

The United Laboratories International Holdings Limited

Sichuan Kelun Pharmaceutical

Jiangxi Huabang

North China Pharmaceutical Company

Henan Huaxing

Harbin Pharmaceutical Group

Shanghai Shyndec Pharmaceutical

Fuan Pharmaceutical group

Yili Chuanning Biotechnology

Changzhou RedSun

Centrient Pharmaceuticals

XINXIANG BEST PHARMACEUTICAL

United Laboratories

TUL

Sinopharm Weiqida Pharmaceutical

Sichuan Huaxin

Qilu Tianhe Pharma

Novartis Sandoz Anti-Infectives

LKPC

Kelun

Jiangxi Fushine Pharmaceutical

Huayao Group

Hayao

E-Cspc

CSPC Zhongrun

Penicillin Intermediate Segment by Type

6-APA

Penicillin G and V Potassium Salt

Others

Penicillin Intermediate Segment by Application

Penicillin Antibiotics

Cephalosporin Antibiotics

Penicillin Intermediate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Penicillin Intermediate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Penicillin Intermediate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Penicillin Intermediate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Penicillin Intermediate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Penicillin Intermediate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Penicillin Intermediate sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Penicillin Intermediate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 6-APA Major Manufacturers Table 3. Penicillin G and V Potassium Salt Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Penicillin Intermediate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Penicillin Antibiotics Major Manufacturers Table 7. Cephalosporin Antibiotics Major Manufacturers Table 8. Penicillin Intermediate Industry Trends Table 9. Penicillin Intermediate Industry Drivers Table 10. Penicillin Intermediate Industry Opportunities and Challenges Table 11. Penicillin Intermediate Industry Restraints Table 12. Global Penicillin Intermediate Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Penicillin Intermediate Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Penicillin Intermediate Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Penicillin Intermediate Revenue Market Share by Region (2021-2026) Table 16. Global Penicillin Intermediate Revenue Market Share by Region (2027-2032) Table 17. Global Penicillin Intermediate Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 18. Global Penicillin Intermediate Sales by Region (2021-2026) & (Tons) Table 19. Global Penicillin Intermediate Sales by Region (2027-2032) & (Tons) Table 20. Global Penicillin Intermediate Sales Market Share by Region (2021-2026) Table 21. Global Penicillin Intermediate Sales Market Share by Region (2027-2032) Table 22. Global Penicillin Intermediate Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Penicillin Intermediate Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Penicillin Intermediate Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Penicillin Intermediate Sales Market Share by Manufacturers (2021-2026) Table 26. Global Penicillin Intermediate Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 27. Global Penicillin Intermediate Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Penicillin Intermediate Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Penicillin Intermediate Manufacturers, Product Type & Application Table 30. Global Penicillin Intermediate Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Penicillin Intermediate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Penicillin Intermediate Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Penicillin Intermediate Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Penicillin Intermediate Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Penicillin Intermediate Revenue Market Share by Type (2021-2026) Table 37. Global Penicillin Intermediate Revenue Market Share by Type (2027-2032) Table 38. Global Penicillin Intermediate Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 39. Global Penicillin Intermediate Sales by Type (2021-2026) & (Tons) Table 40. Global Penicillin Intermediate Sales by Type (2027-2032) & (Tons) Table 41. Global Penicillin Intermediate Sales Market Share by Type (2021-2026) Table 42. Global Penicillin Intermediate Sales Market Share by Type (2027-2032) Table 43. Global Penicillin Intermediate Price by Type (2021-2026) & (US$/Kg) Table 44. Global Penicillin Intermediate Price by Type (2027-2032) & (US$/Kg) Table 45. Global Penicillin Intermediate Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Penicillin Intermediate Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Penicillin Intermediate Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Penicillin Intermediate Revenue Market Share by Application (2021-2026) Table 49. Global Penicillin Intermediate Revenue Market Share by Application (2027-2032) Table 50. Global Penicillin Intermediate Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 51. Global Penicillin Intermediate Sales by Application (2021-2026) & (Tons) Table 52. Global Penicillin Intermediate Sales by Application (2027-2032) & (Tons) Table 53. Global Penicillin Intermediate Sales Market Share by Application (2021-2026) Table 54. Global Penicillin Intermediate Sales Market Share by Application (2027-2032) Table 55. Global Penicillin Intermediate Price by Application (2021-2026) & (US$/Kg) Table 56. Global Penicillin Intermediate Price by Application (2027-2032) & (US$/Kg) Table 57. Sinopharm Weiqida Pharmaceutical Company Information Table 58. Sinopharm Weiqida Pharmaceutical Business Overview Table 59. Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 60. Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Product Portfolio Table 61. Sinopharm Weiqida Pharmaceutical Recent Development Table 62. Kasugamycin hydrochloride Company Information Table 63. Kasugamycin hydrochloride Business Overview Table 64. Kasugamycin hydrochloride Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 65. Kasugamycin hydrochloride Penicillin Intermediate Product Portfolio Table 66. Kasugamycin hydrochloride Recent Development Table 67. Shanghai Hongsheng Company Information Table 68. Shanghai Hongsheng Business Overview Table 69. Shanghai Hongsheng Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 70. Shanghai Hongsheng Penicillin Intermediate Product Portfolio Table 71. Shanghai Hongsheng Recent Development Table 72. Apeloa Pharmaceutical Company Information Table 73. Apeloa Pharmaceutical Business Overview Table 74. Apeloa Pharmaceutical Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 75. Apeloa Pharmaceutical Penicillin Intermediate Product Portfolio Table 76. Apeloa Pharmaceutical Recent Development Table 77. The United Laboratories International Holdings Limited Company Information Table 78. The United Laboratories International Holdings Limited Business Overview Table 79. The United Laboratories International Holdings Limited Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 80. The United Laboratories International Holdings Limited Penicillin Intermediate Product Portfolio Table 81. The United Laboratories International Holdings Limited Recent Development Table 82. Sichuan Kelun Pharmaceutical Company Information Table 83. Sichuan Kelun Pharmaceutical Business Overview Table 84. Sichuan Kelun Pharmaceutical Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 85. Sichuan Kelun Pharmaceutical Penicillin Intermediate Product Portfolio Table 86. Sichuan Kelun Pharmaceutical Recent Development Table 87. Jiangxi Huabang Company Information Table 88. Jiangxi Huabang Business Overview Table 89. Jiangxi Huabang Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 90. Jiangxi Huabang Penicillin Intermediate Product Portfolio Table 91. Jiangxi Huabang Recent Development Table 92. North China Pharmaceutical Company Company Information Table 93. North China Pharmaceutical Company Business Overview Table 94. North China Pharmaceutical Company Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 95. North China Pharmaceutical Company Penicillin Intermediate Product Portfolio Table 96. North China Pharmaceutical Company Recent Development Table 97. Henan Huaxing Company Information Table 98. Henan Huaxing Business Overview Table 99. Henan Huaxing Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 100. Henan Huaxing Penicillin Intermediate Product Portfolio Table 101. Henan Huaxing Recent Development Table 102. Harbin Pharmaceutical Group Company Information Table 103. Harbin Pharmaceutical Group Business Overview Table 104. Harbin Pharmaceutical Group Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 105. Harbin Pharmaceutical Group Penicillin Intermediate Product Portfolio Table 106. Harbin Pharmaceutical Group Recent Development Table 107. Shanghai Shyndec Pharmaceutical Company Information Table 108. Shanghai Shyndec Pharmaceutical Business Overview Table 109. Shanghai Shyndec Pharmaceutical Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 110. Shanghai Shyndec Pharmaceutical Penicillin Intermediate Product Portfolio Table 111. Shanghai Shyndec Pharmaceutical Recent Development Table 112. Fuan Pharmaceutical group Company Information Table 113. Fuan Pharmaceutical group Business Overview Table 114. Fuan Pharmaceutical group Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 115. Fuan Pharmaceutical group Penicillin Intermediate Product Portfolio Table 116. Fuan Pharmaceutical group Recent Development Table 117. Yili Chuanning Biotechnology Company Information Table 118. Yili Chuanning Biotechnology Business Overview Table 119. Yili Chuanning Biotechnology Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 120. Yili Chuanning Biotechnology Penicillin Intermediate Product Portfolio Table 121. Yili Chuanning Biotechnology Recent Development Table 122. Changzhou RedSun Company Information Table 123. Changzhou RedSun Business Overview Table 124. Changzhou RedSun Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 125. Changzhou RedSun Penicillin Intermediate Product Portfolio Table 126. Changzhou RedSun Recent Development Table 127. Centrient Pharmaceuticals Company Information Table 128. Centrient Pharmaceuticals Business Overview Table 129. Centrient Pharmaceuticals Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 130. Centrient Pharmaceuticals Penicillin Intermediate Product Portfolio Table 131. Centrient Pharmaceuticals Recent Development Table 132. XINXIANG BEST PHARMACEUTICAL Company Information Table 133. XINXIANG BEST PHARMACEUTICAL Business Overview Table 134. XINXIANG BEST PHARMACEUTICAL Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 135. XINXIANG BEST PHARMACEUTICAL Penicillin Intermediate Product Portfolio Table 136. XINXIANG BEST PHARMACEUTICAL Recent Development Table 137. United Laboratories Company Information Table 138. United Laboratories Business Overview Table 139. United Laboratories Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 140. United Laboratories Penicillin Intermediate Product Portfolio Table 141. United Laboratories Recent Development Table 142. TUL Company Information Table 143. TUL Business Overview Table 144. TUL Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 145. TUL Penicillin Intermediate Product Portfolio Table 146. TUL Recent Development Table 147. Sinopharm Weiqida Pharmaceutical Company Information Table 148. Sinopharm Weiqida Pharmaceutical Business Overview Table 149. Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 150. Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Product Portfolio Table 151. Sinopharm Weiqida Pharmaceutical Recent Development Table 152. Sichuan Huaxin Company Information Table 153. Sichuan Huaxin Business Overview Table 154. Sichuan Huaxin Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 155. Sichuan Huaxin Penicillin Intermediate Product Portfolio Table 156. Sichuan Huaxin Recent Development Table 157. Qilu Tianhe Pharma Company Information Table 158. Qilu Tianhe Pharma Business Overview Table 159. Qilu Tianhe Pharma Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 160. Qilu Tianhe Pharma Penicillin Intermediate Product Portfolio Table 161. Qilu Tianhe Pharma Recent Development Table 162. Novartis Sandoz Anti-Infectives Company Information Table 163. Novartis Sandoz Anti-Infectives Business Overview Table 164. Novartis Sandoz Anti-Infectives Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 165. Novartis Sandoz Anti-Infectives Penicillin Intermediate Product Portfolio Table 166. Novartis Sandoz Anti-Infectives Recent Development Table 167. LKPC Company Information Table 168. LKPC Business Overview Table 169. LKPC Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 170. LKPC Penicillin Intermediate Product Portfolio Table 171. LKPC Recent Development Table 172. Kelun Company Information Table 173. Kelun Business Overview Table 174. Kelun Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 175. Kelun Penicillin Intermediate Product Portfolio Table 176. Kelun Recent Development Table 177. Jiangxi Fushine Pharmaceutical Company Information Table 178. Jiangxi Fushine Pharmaceutical Business Overview Table 179. Jiangxi Fushine Pharmaceutical Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 180. Jiangxi Fushine Pharmaceutical Penicillin Intermediate Product Portfolio Table 181. Jiangxi Fushine Pharmaceutical Recent Development Table 182. Huayao Group Company Information Table 183. Huayao Group Business Overview Table 184. Huayao Group Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 185. Huayao Group Penicillin Intermediate Product Portfolio Table 186. Huayao Group Recent Development Table 187. Hayao Company Information Table 188. Hayao Business Overview Table 189. Hayao Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 190. Hayao Penicillin Intermediate Product Portfolio Table 191. Hayao Recent Development Table 192. E-Cspc Company Information Table 193. E-Cspc Business Overview Table 194. E-Cspc Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 195. E-Cspc Penicillin Intermediate Product Portfolio Table 196. E-Cspc Recent Development Table 197. CSPC Zhongrun Company Information Table 198. CSPC Zhongrun Business Overview Table 199. CSPC Zhongrun Penicillin Intermediate Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 200. CSPC Zhongrun Penicillin Intermediate Product Portfolio Table 201. CSPC Zhongrun Recent Development Table 202. North America Penicillin Intermediate Revenue by Type (2021-2026) & (US$ Million) Table 203. North America Penicillin Intermediate Revenue by Type (2027-2032) & (US$ Million) Table 204. North America Penicillin Intermediate Sales by Type (2021-2026) & (Tons) Table 205. North America Penicillin Intermediate Sales by Type (2027-2032) & (Tons) Table 206. North America Penicillin Intermediate Sales Price by Type (2021-2026) & (US$/Kg) Table 207. North America Penicillin Intermediate Sales Price by Type (2027-2032) & (US$/Kg) Table 208. North America Penicillin Intermediate Revenue by Application (2021-2026) & (US$ Million) Table 209. North America Penicillin Intermediate Revenue by Application (2027-2032) & (US$ Million) Table 210. North America Penicillin Intermediate Sales by Application (2021-2026) & (Tons) Table 211. North America Penicillin Intermediate Sales by Application (2027-2032) & (Tons) Table 212. North America Penicillin Intermediate Sales Price by Application (2021-2026) & (US$/Kg) Table 213. North America Penicillin Intermediate Sales Price by Application (2027-2032) & (US$/Kg) Table 214. North America Penicillin Intermediate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 215. North America Penicillin Intermediate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 216. North America Penicillin Intermediate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 217. North America Penicillin Intermediate Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 218. North America Penicillin Intermediate Sales by Country (2021-2026) & (Tons) Table 219. North America Penicillin Intermediate Sales by Country (2027-2032) & (Tons) Table 220. North America Penicillin Intermediate Sales Price by Country (2021-2026) & (US$/Kg) Table 221. North America Penicillin Intermediate Sales Price by Country (2027-2032) & (US$/Kg) Table 222. United States Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 223. Canada Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 224. Europe Penicillin Intermediate Revenue by Type (2021-2026) & (US$ Million) Table 225. Europe Penicillin Intermediate Revenue by Type (2027-2032) & (US$ Million) Table 226. Europe Penicillin Intermediate Sales by Type (2021-2026) & (Tons) Table 227. Europe Penicillin Intermediate Sales by Type (2027-2032) & (Tons) Table 228. Europe Penicillin Intermediate Sales Price by Type (2021-2026) & (US$/Kg) Table 229. Europe Penicillin Intermediate Sales Price by Type (2027-2032) & (US$/Kg) Table 230. Europe Penicillin Intermediate Revenue by Application (2021-2026) & (US$ Million) Table 231. Europe Penicillin Intermediate Revenue by Application (2027-2032) & (US$ Million) Table 232. Europe Penicillin Intermediate Sales by Application (2021-2026) & (Tons) Table 233. Europe Penicillin Intermediate Sales by Application (2027-2032) & (Tons) Table 234. Europe Penicillin Intermediate Sales Price by Application (2021-2026) & (US$/Kg) Table 235. Europe Penicillin Intermediate Sales Price by Application (2027-2032) & (US$/Kg) Table 236. Europe Penicillin Intermediate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 237. Europe Penicillin Intermediate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 238. Europe Penicillin Intermediate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 239. Europe Penicillin Intermediate Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 240. Europe Penicillin Intermediate Sales by Country (2021-2026) & (Tons) Table 241. Europe Penicillin Intermediate Sales by Country (2027-2032) & (Tons) Table 242. Europe Penicillin Intermediate Sales Price by Country (2021-2026) & (US$/Kg) Table 243. Europe Penicillin Intermediate Sales Price by Country (2027-2032) & (US$/Kg) Table 244. Germany Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 245. France Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 246. U.K. Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 247. Italy Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 248. Netherlands Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 249. China Penicillin Intermediate Revenue by Type (2021-2026) & (US$ Million) Table 250. China Penicillin Intermediate Revenue by Type (2027-2032) & (US$ Million) Table 251. China Penicillin Intermediate Sales by Type (2021-2026) & (Tons) Table 252. China Penicillin Intermediate Sales by Type (2027-2032) & (Tons) Table 253. China Penicillin Intermediate Sales Price by Type (2021-2026) & (US$/Kg) Table 254. China Penicillin Intermediate Sales Price by Type (2027-2032) & (US$/Kg) Table 255. China Penicillin Intermediate Revenue by Application (2021-2026) & (US$ Million) Table 256. China Penicillin Intermediate Revenue by Application (2027-2032) & (US$ Million) Table 257. China Penicillin Intermediate Sales by Application (2021-2026) & (Tons) Table 258. China Penicillin Intermediate Sales by Application (2027-2032) & (Tons) Table 259. China Penicillin Intermediate Sales Price by Application (2021-2026) & (US$/Kg) Table 260. China Penicillin Intermediate Sales Price by Application (2027-2032) & (US$/Kg) Table 261. Asia Penicillin Intermediate Revenue by Type (2021-2026) & (US$ Million) Table 262. Asia Penicillin Intermediate Revenue by Type (2027-2032) & (US$ Million) Table 263. Asia Penicillin Intermediate Sales by Type (2021-2026) & (Tons) Table 264. Asia Penicillin Intermediate Sales by Type (2027-2032) & (Tons) Table 265. Asia Penicillin Intermediate Sales Price by Type (2021-2026) & (US$/Kg) Table 266. Asia Penicillin Intermediate Sales Price by Type (2027-2032) & (US$/Kg) Table 267. Asia Penicillin Intermediate Revenue by Application (2021-2026) & (US$ Million) Table 268. Asia Penicillin Intermediate Revenue by Application (2027-2032) & (US$ Million) Table 269. Asia Penicillin Intermediate Sales by Application (2021-2026) & (Tons) Table 270. Asia Penicillin Intermediate Sales by Application (2027-2032) & (Tons) Table 271. Asia Penicillin Intermediate Sales Price by Application (2021-2026) & (US$/Kg) Table 272. Asia Penicillin Intermediate Sales Price by Application (2027-2032) & (US$/Kg) Table 273. Asia Penicillin Intermediate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 274. Asia Penicillin Intermediate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 275. Asia Penicillin Intermediate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 276. Asia Penicillin Intermediate Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 277. Asia Penicillin Intermediate Sales by Country (2021-2026) & (Tons) Table 278. Asia Penicillin Intermediate Sales by Country (2027-2032) & (Tons) Table 279. Asia Penicillin Intermediate Sales Price by Country (2021-2026) & (US$/Kg) Table 280. Asia Penicillin Intermediate Sales Price by Country (2027-2032) & (US$/Kg) Table 281. Japan Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 282. South Korea Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 283. India Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 284. Australia Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 285. China Taiwan Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 286. Southeast Asia Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 287. SAMEA Penicillin Intermediate Revenue by Type (2021-2026) & (US$ Million) Table 288. SAMEA Penicillin Intermediate Revenue by Type (2027-2032) & (US$ Million) Table 289. SAMEA Penicillin Intermediate Sales by Type (2021-2026) & (Tons) Table 290. SAMEA Penicillin Intermediate Sales by Type (2027-2032) & (Tons) Table 291. SAMEA Penicillin Intermediate Sales Price by Type (2021-2026) & (US$/Kg) Table 292. SAMEA Penicillin Intermediate Sales Price by Type (2027-2032) & (US$/Kg) Table 293. SAMEA Penicillin Intermediate Revenue by Application (2021-2026) & (US$ Million) Table 294. SAMEA Penicillin Intermediate Revenue by Application (2027-2032) & (US$ Million) Table 295. SAMEA Penicillin Intermediate Sales by Application (2021-2026) & (Tons) Table 296. SAMEA Penicillin Intermediate Sales by Application (2027-2032) & (Tons) Table 297. SAMEA Penicillin Intermediate Sales Price by Application (2021-2026) & (US$/Kg) Table 298. SAMEA Penicillin Intermediate Sales Price by Application (2027-2032) & (US$/Kg) Table 299. SAMEA Penicillin Intermediate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 300. SAMEA Penicillin Intermediate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 301. SAMEA Penicillin Intermediate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 302. SAMEA Penicillin Intermediate Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 303. SAMEA Penicillin Intermediate Sales by Country (2021-2026) & (Tons) Table 304. SAMEA Penicillin Intermediate Sales by Country (2027-2032) & (Tons) Table 305. SAMEA Penicillin Intermediate Sales Price by Country (2021-2026) & (US$/Kg) Table 306. SAMEA Penicillin Intermediate Sales Price by Country (2027-2032) & (US$/Kg) Table 307. Brazil Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 308. Argentina Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 309. Chile Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 310. Colombia Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 311. Peru Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 312. Saudi Arabia Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 313. Israel Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 314. UAE Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 315. Turkey Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 316. Iran Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 317. Egypt Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Table 318. Key Raw Materials Table 319. Raw Materials Key Suppliers Table 320. Penicillin Intermediate Distributors List Table 321. Penicillin Intermediate Customers List Table 322. Research Programs/Design for This Report Table 323. Authors List of This Report Table 324. Secondary Sources Table 325. Primary Sources List of Figures Figure 1. Penicillin Intermediate Image Figure 2. Global Penicillin Intermediate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Penicillin Intermediate Market Size Share 2021 VS 2025 VS 2032 Figure 4. 6-APA Image Figure 5. Penicillin G and V Potassium Salt Image Figure 6. Others Image Figure 7. Global Penicillin Intermediate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Penicillin Intermediate Market Size Share 2021 VS 2025 VS 2032 Figure 9. Penicillin Antibiotics Image Figure 10. Cephalosporin Antibiotics Image Figure 11. Global Penicillin Intermediate Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Penicillin Intermediate Revenue (2021-2032) & (US$ Million) Figure 13. Global Penicillin Intermediate Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Penicillin Intermediate Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Penicillin Intermediate Revenue Market Share by Region (2021-2032) Figure 16. Global Penicillin Intermediate Sales (2021-2032) & (Tons) Figure 17. Global Penicillin Intermediate Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 18. Global Penicillin Intermediate Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Penicillin Intermediate Sales YoY (2021-2032) & (Tons) Figure 20. Europe Penicillin Intermediate Sales YoY (2021-2032) & (Tons) Figure 21. China Penicillin Intermediate Sales YoY (2021-2032) & (Tons) Figure 22. Asia (Excluding China) Penicillin Intermediate Sales YoY (2021-2032) & (Tons) Figure 23. South America, Middle East and Africa Penicillin Intermediate Sales YoY (2021-2032) & (Tons) Figure 24. Global Penicillin Intermediate Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Penicillin Intermediate Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Penicillin Intermediate Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Penicillin Intermediate Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Penicillin Intermediate Revenue Market Share by Type (2021-2032) Figure 30. Global Penicillin Intermediate Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 31. Global Penicillin Intermediate Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Penicillin Intermediate Sales Market Share by Type (2021-2032) Figure 33. Global Penicillin Intermediate Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Penicillin Intermediate Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Penicillin Intermediate Revenue Market Share by Application (2021-2032) Figure 36. Global Penicillin Intermediate Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 37. Global Penicillin Intermediate Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Penicillin Intermediate Sales Market Share by Application (2021-2032) Figure 39. North America Penicillin Intermediate Revenue Share by Type (2021-2032) Figure 40. North America Penicillin Intermediate Sales Share by Type (2021-2032) Figure 41. North America Penicillin Intermediate Revenue Share by Application (2021-2032) Figure 42. North America Penicillin Intermediate Sales Share by Application (2021-2032) Figure 43. North America Penicillin Intermediate Revenue Share by Country (2021-2032) Figure 44. North America Penicillin Intermediate Sales Share by Country (2021-2032) Figure 45. Europe Penicillin Intermediate Revenue Share by Type (2021-2032) Figure 46. Europe Penicillin Intermediate Sales Share by Type (2021-2032) Figure 47. Europe Penicillin Intermediate Revenue Share by Application (2021-2032) Figure 48. Europe Penicillin Intermediate Sales Share by Application (2021-2032) Figure 49. Europe Penicillin Intermediate Revenue Share by Country (2021-2032) Figure 50. Europe Penicillin Intermediate Sales Share by Country (2021-2032) Figure 51. China Penicillin Intermediate Revenue Share by Type (2021-2032) Figure 52. China Penicillin Intermediate Sales Share by Type (2021-2032) Figure 53. China Penicillin Intermediate Revenue Share by Application (2021-2032) Figure 54. China Penicillin Intermediate Sales Share by Application (2021-2032) Figure 55. Asia Penicillin Intermediate Revenue Share by Type (2021-2032) Figure 56. Asia Penicillin Intermediate Sales Share by Type (2021-2032) Figure 57. Asia Penicillin Intermediate Revenue Share by Application (2021-2032) Figure 58. Asia Penicillin Intermediate Sales Share by Application (2021-2032) Figure 59. Asia Penicillin Intermediate Revenue Share by Country (2021-2032) Figure 60. Asia Penicillin Intermediate Sales Share by Country (2021-2032) Figure 61. SAMEA Penicillin Intermediate Revenue Share by Type (2021-2032) Figure 62. SAMEA Penicillin Intermediate Sales Share by Type (2021-2032) Figure 63. SAMEA Penicillin Intermediate Revenue Share by Application (2021-2032) Figure 64. SAMEA Penicillin Intermediate Sales Share by App

Scope & coverage.

Types
  • 6-APA
  • Penicillin G and V Potassium Salt
  • Others
Applications
  • Penicillin Antibiotics
  • Cephalosporin Antibiotics
Companies covered
  • Sinopharm Weiqida Pharmaceutical
  • Kasugamycin hydrochloride
  • Shanghai Hongsheng
  • Apeloa Pharmaceutical
  • The United Laboratories International Holdings Limited
  • Sichuan Kelun Pharmaceutical
  • Jiangxi Huabang
  • North China Pharmaceutical Company
  • Henan Huaxing
  • Harbin Pharmaceutical Group
  • Shanghai Shyndec Pharmaceutical
  • Fuan Pharmaceutical group
  • Yili Chuanning Biotechnology
  • Changzhou RedSun
  • Centrient Pharmaceuticals
  • XINXIANG BEST PHARMACEUTICAL
  • United Laboratories
  • TUL
  • Sinopharm Weiqida Pharmaceutical
  • Sichuan Huaxin
  • Qilu Tianhe Pharma
  • Novartis Sandoz Anti-Infectives
  • LKPC
  • Kelun
  • Jiangxi Fushine Pharmaceutical
  • Huayao Group
  • Hayao
  • E-Cspc
  • CSPC Zhongrun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Penicillin Intermediate Market by Type
  3. 1.2.1 Global Penicillin Intermediate Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 6-APA
  5. 1.2.3 Penicillin G and V Potassium Salt
  6. 1.2.4 Others
  7. 1.3 Penicillin Intermediate Market by Application
  8. 1.3.1 Global Penicillin Intermediate Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Penicillin Antibiotics
  10. 1.3.3 Cephalosporin Antibiotics
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Penicillin Intermediate Market Dynamics
  1. 2.1 Penicillin Intermediate Industry Trends
  2. 2.2 Penicillin Intermediate Industry Drivers
  3. 2.3 Penicillin Intermediate Industry Opportunities and Challenges
  4. 2.4 Penicillin Intermediate Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Penicillin Intermediate Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Penicillin Intermediate Revenue by Region
  3. 3.2.1 Global Penicillin Intermediate Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Penicillin Intermediate Revenue by Region (2021-2026)
  5. 3.2.3 Global Penicillin Intermediate Revenue by Region (2027-2032)
  6. 3.2.4 Global Penicillin Intermediate Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Penicillin Intermediate Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Penicillin Intermediate Sales by Region
  9. 3.4.1 Global Penicillin Intermediate Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Penicillin Intermediate Sales by Region (2021-2026)
  11. 3.4.3 Global Penicillin Intermediate Sales by Region (2027-2032)
  12. 3.4.4 Global Penicillin Intermediate Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Penicillin Intermediate Revenue by Manufacturers
  2. 4.1.1 Global Penicillin Intermediate Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Penicillin Intermediate Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Penicillin Intermediate Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Penicillin Intermediate Sales by Manufacturers
  6. 4.2.1 Global Penicillin Intermediate Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Penicillin Intermediate Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Penicillin Intermediate Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Penicillin Intermediate Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Penicillin Intermediate Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Penicillin Intermediate Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Penicillin Intermediate Manufacturers, Product Type & Application
  13. 4.7 Global Penicillin Intermediate Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Penicillin Intermediate Market CR5 and HHI
  16. 4.8.2 2025 Penicillin Intermediate Tier 1, Tier 2, and Tier 3
5 Penicillin Intermediate Market by Type
  1. 5.1 Global Penicillin Intermediate Revenue by Type
  2. 5.1.1 Global Penicillin Intermediate Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Penicillin Intermediate Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Penicillin Intermediate Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Penicillin Intermediate Sales by Type
  6. 5.2.1 Global Penicillin Intermediate Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Penicillin Intermediate Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Penicillin Intermediate Sales Market Share by Type (2021-2032)
  9. 5.3 Global Penicillin Intermediate Price by Type
6 Penicillin Intermediate Market by Application
  1. 6.1 Global Penicillin Intermediate Revenue by Application
  2. 6.1.1 Global Penicillin Intermediate Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Penicillin Intermediate Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Penicillin Intermediate Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Penicillin Intermediate Sales by Application
  6. 6.2.1 Global Penicillin Intermediate Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Penicillin Intermediate Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Penicillin Intermediate Sales Market Share by Application (2021-2032)
  9. 6.3 Global Penicillin Intermediate Price by Application
7 Company Profiles
  1. 7.1 Sinopharm Weiqida Pharmaceutical
  2. 7.1.1 Sinopharm Weiqida Pharmaceutical Company Information
  3. 7.1.2 Sinopharm Weiqida Pharmaceutical Business Overview
  4. 7.1.3 Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Product Portfolio
  6. 7.1.5 Sinopharm Weiqida Pharmaceutical Recent Developments
  7. 7.2 Kasugamycin hydrochloride
  8. 7.2.1 Kasugamycin hydrochloride Company Information
  9. 7.2.2 Kasugamycin hydrochloride Business Overview
  10. 7.2.3 Kasugamycin hydrochloride Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Kasugamycin hydrochloride Penicillin Intermediate Product Portfolio
  12. 7.2.5 Kasugamycin hydrochloride Recent Developments
  13. 7.3 Shanghai Hongsheng
  14. 7.3.1 Shanghai Hongsheng Company Information
  15. 7.3.2 Shanghai Hongsheng Business Overview
  16. 7.3.3 Shanghai Hongsheng Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Shanghai Hongsheng Penicillin Intermediate Product Portfolio
  18. 7.3.5 Shanghai Hongsheng Recent Developments
  19. 7.4 Apeloa Pharmaceutical
  20. 7.4.1 Apeloa Pharmaceutical Company Information
  21. 7.4.2 Apeloa Pharmaceutical Business Overview
  22. 7.4.3 Apeloa Pharmaceutical Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Apeloa Pharmaceutical Penicillin Intermediate Product Portfolio
  24. 7.4.5 Apeloa Pharmaceutical Recent Developments
  25. 7.5 The United Laboratories International Holdings Limited
  26. 7.5.1 The United Laboratories International Holdings Limited Company Information
  27. 7.5.2 The United Laboratories International Holdings Limited Business Overview
  28. 7.5.3 The United Laboratories International Holdings Limited Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 The United Laboratories International Holdings Limited Penicillin Intermediate Product Portfolio
  30. 7.5.5 The United Laboratories International Holdings Limited Recent Developments
  31. 7.6 Sichuan Kelun Pharmaceutical
  32. 7.6.1 Sichuan Kelun Pharmaceutical Company Information
  33. 7.6.2 Sichuan Kelun Pharmaceutical Business Overview
  34. 7.6.3 Sichuan Kelun Pharmaceutical Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sichuan Kelun Pharmaceutical Penicillin Intermediate Product Portfolio
  36. 7.6.5 Sichuan Kelun Pharmaceutical Recent Developments
  37. 7.7 Jiangxi Huabang
  38. 7.7.1 Jiangxi Huabang Company Information
  39. 7.7.2 Jiangxi Huabang Business Overview
  40. 7.7.3 Jiangxi Huabang Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Jiangxi Huabang Penicillin Intermediate Product Portfolio
  42. 7.7.5 Jiangxi Huabang Recent Developments
  43. 7.8 North China Pharmaceutical Company
  44. 7.8.1 North China Pharmaceutical Company Company Information
  45. 7.8.2 North China Pharmaceutical Company Business Overview
  46. 7.8.3 North China Pharmaceutical Company Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 North China Pharmaceutical Company Penicillin Intermediate Product Portfolio
  48. 7.8.5 North China Pharmaceutical Company Recent Developments
  49. 7.9 Henan Huaxing
  50. 7.9.1 Henan Huaxing Company Information
  51. 7.9.2 Henan Huaxing Business Overview
  52. 7.9.3 Henan Huaxing Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Henan Huaxing Penicillin Intermediate Product Portfolio
  54. 7.9.5 Henan Huaxing Recent Developments
  55. 7.10 Harbin Pharmaceutical Group
  56. 7.10.1 Harbin Pharmaceutical Group Company Information
  57. 7.10.2 Harbin Pharmaceutical Group Business Overview
  58. 7.10.3 Harbin Pharmaceutical Group Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Harbin Pharmaceutical Group Penicillin Intermediate Product Portfolio
  60. 7.10.5 Harbin Pharmaceutical Group Recent Developments
  61. 7.11 Shanghai Shyndec Pharmaceutical
  62. 7.11.1 Shanghai Shyndec Pharmaceutical Company Information
  63. 7.11.2 Shanghai Shyndec Pharmaceutical Business Overview
  64. 7.11.3 Shanghai Shyndec Pharmaceutical Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Shanghai Shyndec Pharmaceutical Penicillin Intermediate Product Portfolio
  66. 7.11.5 Shanghai Shyndec Pharmaceutical Recent Developments
  67. 7.12 Fuan Pharmaceutical group
  68. 7.12.1 Fuan Pharmaceutical group Company Information
  69. 7.12.2 Fuan Pharmaceutical group Business Overview
  70. 7.12.3 Fuan Pharmaceutical group Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Fuan Pharmaceutical group Penicillin Intermediate Product Portfolio
  72. 7.12.5 Fuan Pharmaceutical group Recent Developments
  73. 7.13 Yili Chuanning Biotechnology
  74. 7.13.1 Yili Chuanning Biotechnology Company Information
  75. 7.13.2 Yili Chuanning Biotechnology Business Overview
  76. 7.13.3 Yili Chuanning Biotechnology Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Yili Chuanning Biotechnology Penicillin Intermediate Product Portfolio
  78. 7.13.5 Yili Chuanning Biotechnology Recent Developments
  79. 7.14 Changzhou RedSun
  80. 7.14.1 Changzhou RedSun Company Information
  81. 7.14.2 Changzhou RedSun Business Overview
  82. 7.14.3 Changzhou RedSun Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Changzhou RedSun Penicillin Intermediate Product Portfolio
  84. 7.14.5 Changzhou RedSun Recent Developments
  85. 7.15 Centrient Pharmaceuticals
  86. 7.15.1 Centrient Pharmaceuticals Company Information
  87. 7.15.2 Centrient Pharmaceuticals Business Overview
  88. 7.15.3 Centrient Pharmaceuticals Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Centrient Pharmaceuticals Penicillin Intermediate Product Portfolio
  90. 7.15.5 Centrient Pharmaceuticals Recent Developments
  91. 7.16 XINXIANG BEST PHARMACEUTICAL
  92. 7.16.1 XINXIANG BEST PHARMACEUTICAL Company Information
  93. 7.16.2 XINXIANG BEST PHARMACEUTICAL Business Overview
  94. 7.16.3 XINXIANG BEST PHARMACEUTICAL Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 XINXIANG BEST PHARMACEUTICAL Penicillin Intermediate Product Portfolio
  96. 7.16.5 XINXIANG BEST PHARMACEUTICAL Recent Developments
  97. 7.17 United Laboratories
  98. 7.17.1 United Laboratories Company Information
  99. 7.17.2 United Laboratories Business Overview
  100. 7.17.3 United Laboratories Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 United Laboratories Penicillin Intermediate Product Portfolio
  102. 7.17.5 United Laboratories Recent Developments
  103. 7.18 TUL
  104. 7.18.1 TUL Company Information
  105. 7.18.2 TUL Business Overview
  106. 7.18.3 TUL Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 TUL Penicillin Intermediate Product Portfolio
  108. 7.18.5 TUL Recent Developments
  109. 7.19 Sinopharm Weiqida Pharmaceutical
  110. 7.19.1 Sinopharm Weiqida Pharmaceutical Company Information
  111. 7.19.2 Sinopharm Weiqida Pharmaceutical Business Overview
  112. 7.19.3 Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Sinopharm Weiqida Pharmaceutical Penicillin Intermediate Product Portfolio
  114. 7.19.5 Sinopharm Weiqida Pharmaceutical Recent Developments
  115. 7.20 Sichuan Huaxin
  116. 7.20.1 Sichuan Huaxin Company Information
  117. 7.20.2 Sichuan Huaxin Business Overview
  118. 7.20.3 Sichuan Huaxin Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Sichuan Huaxin Penicillin Intermediate Product Portfolio
  120. 7.20.5 Sichuan Huaxin Recent Developments
  121. 7.21 Qilu Tianhe Pharma
  122. 7.21.1 Qilu Tianhe Pharma Company Information
  123. 7.21.2 Qilu Tianhe Pharma Business Overview
  124. 7.21.3 Qilu Tianhe Pharma Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Qilu Tianhe Pharma Penicillin Intermediate Product Portfolio
  126. 7.21.5 Qilu Tianhe Pharma Recent Developments
  127. 7.22 Novartis Sandoz Anti-Infectives
  128. 7.22.1 Novartis Sandoz Anti-Infectives Company Information
  129. 7.22.2 Novartis Sandoz Anti-Infectives Business Overview
  130. 7.22.3 Novartis Sandoz Anti-Infectives Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Novartis Sandoz Anti-Infectives Penicillin Intermediate Product Portfolio
  132. 7.22.5 Novartis Sandoz Anti-Infectives Recent Developments
  133. 7.23 LKPC
  134. 7.23.1 LKPC Company Information
  135. 7.23.2 LKPC Business Overview
  136. 7.23.3 LKPC Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 LKPC Penicillin Intermediate Product Portfolio
  138. 7.23.5 LKPC Recent Developments
  139. 7.24 Kelun
  140. 7.24.1 Kelun Company Information
  141. 7.24.2 Kelun Business Overview
  142. 7.24.3 Kelun Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 Kelun Penicillin Intermediate Product Portfolio
  144. 7.24.5 Kelun Recent Developments
  145. 7.25 Jiangxi Fushine Pharmaceutical
  146. 7.25.1 Jiangxi Fushine Pharmaceutical Company Information
  147. 7.25.2 Jiangxi Fushine Pharmaceutical Business Overview
  148. 7.25.3 Jiangxi Fushine Pharmaceutical Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  149. 7.25.4 Jiangxi Fushine Pharmaceutical Penicillin Intermediate Product Portfolio
  150. 7.25.5 Jiangxi Fushine Pharmaceutical Recent Developments
  151. 7.26 Huayao Group
  152. 7.26.1 Huayao Group Company Information
  153. 7.26.2 Huayao Group Business Overview
  154. 7.26.3 Huayao Group Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  155. 7.26.4 Huayao Group Penicillin Intermediate Product Portfolio
  156. 7.26.5 Huayao Group Recent Developments
  157. 7.27 Hayao
  158. 7.27.1 Hayao Company Information
  159. 7.27.2 Hayao Business Overview
  160. 7.27.3 Hayao Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  161. 7.27.4 Hayao Penicillin Intermediate Product Portfolio
  162. 7.27.5 Hayao Recent Developments
  163. 7.28 E-Cspc
  164. 7.28.1 E-Cspc Company Information
  165. 7.28.2 E-Cspc Business Overview
  166. 7.28.3 E-Cspc Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  167. 7.28.4 E-Cspc Penicillin Intermediate Product Portfolio
  168. 7.28.5 E-Cspc Recent Developments
  169. 7.29 CSPC Zhongrun
  170. 7.29.1 CSPC Zhongrun Company Information
  171. 7.29.2 CSPC Zhongrun Business Overview
  172. 7.29.3 CSPC Zhongrun Penicillin Intermediate Sales, Revenue, Price and Gross Margin (2021-2026)
  173. 7.29.4 CSPC Zhongrun Penicillin Intermediate Product Portfolio
  174. 7.29.5 CSPC Zhongrun Recent Developments
8 North America
  1. 8.1 North America Penicillin Intermediate Market Size by Type
  2. 8.1.1 North America Penicillin Intermediate Revenue by Type (2021-2032)
  3. 8.1.2 North America Penicillin Intermediate Sales by Type (2021-2032)
  4. 8.1.3 North America Penicillin Intermediate Price by Type (2021-2032)
  5. 8.2 North America Penicillin Intermediate Market Size by Application
  6. 8.2.1 North America Penicillin Intermediate Revenue by Application (2021-2032)
  7. 8.2.2 North America Penicillin Intermediate Sales by Application (2021-2032)
  8. 8.2.3 North America Penicillin Intermediate Price by Application (2021-2032)
  9. 8.3 North America Penicillin Intermediate Market Size by Country
  10. 8.3.1 North America Penicillin Intermediate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Penicillin Intermediate Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Penicillin Intermediate Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Penicillin Intermediate Market Size by Type
  2. 9.1.1 Europe Penicillin Intermediate Revenue by Type (2021-2032)
  3. 9.1.2 Europe Penicillin Intermediate Sales by Type (2021-2032)
  4. 9.1.3 Europe Penicillin Intermediate Price by Type (2021-2032)
  5. 9.2 Europe Penicillin Intermediate Market Size by Application
  6. 9.2.1 Europe Penicillin Intermediate Revenue by Application (2021-2032)
  7. 9.2.2 Europe Penicillin Intermediate Sales by Application (2021-2032)
  8. 9.2.3 Europe Penicillin Intermediate Price by Application (2021-2032)
  9. 9.3 Europe Penicillin Intermediate Market Size by Country
  10. 9.3.1 Europe Penicillin Intermediate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Penicillin Intermediate Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Penicillin Intermediate Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Penicillin Intermediate Market Size by Type
  2. 10.1.1 China Penicillin Intermediate Revenue by Type (2021-2032)
  3. 10.1.2 China Penicillin Intermediate Sales by Type (2021-2032)
  4. 10.1.3 China Penicillin Intermediate Price by Type (2021-2032)
  5. 10.2 China Penicillin Intermediate Market Size by Application
  6. 10.2.1 China Penicillin Intermediate Revenue by Application (2021-2032)
  7. 10.2.2 China Penicillin Intermediate Sales by Application (2021-2032)
  8. 10.2.3 China Penicillin Intermediate Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Penicillin Intermediate Market Size by Type
  2. 11.1.1 Asia Penicillin Intermediate Revenue by Type (2021-2032)
  3. 11.1.2 Asia Penicillin Intermediate Sales by Type (2021-2032)
  4. 11.1.3 Asia Penicillin Intermediate Price by Type (2021-2032)
  5. 11.2 Asia Penicillin Intermediate Market Size by Application
  6. 11.2.1 Asia Penicillin Intermediate Revenue by Application (2021-2032)
  7. 11.2.2 Asia Penicillin Intermediate Sales by Application (2021-2032)
  8. 11.2.3 Asia Penicillin Intermediate Price by Application (2021-2032)
  9. 11.3 Asia Penicillin Intermediate Market Size by Country
  10. 11.3.1 Asia Penicillin Intermediate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Penicillin Intermediate Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Penicillin Intermediate Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Penicillin Intermediate Market Size by Type
  2. 12.1.1 SAMEA Penicillin Intermediate Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Penicillin Intermediate Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Penicillin Intermediate Price by Type (2021-2032)
  5. 12.2 SAMEA Penicillin Intermediate Market Size by Application
  6. 12.2.1 SAMEA Penicillin Intermediate Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Penicillin Intermediate Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Penicillin Intermediate Price by Application (2021-2032)
  9. 12.3 SAMEA Penicillin Intermediate Market Size by Country
  10. 12.3.1 SAMEA Penicillin Intermediate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Penicillin Intermediate Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Penicillin Intermediate Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Penicillin Intermediate Value Chain Analysis
  2. 13.1.1 Penicillin Intermediate Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Penicillin Intermediate Production Mode & Process
  6. 13.2 Penicillin Intermediate Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Penicillin Intermediate Distributors
  9. 13.2.3 Penicillin Intermediate Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst